Schrödinger to Announce Second Quarter 2022 Financial Results on August 4

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will disclose its second quarter 2022 financial results on August 4, 2022, after market closure. The company will also host a conference call at 4:30 p.m. ET, accessible via its investor website. Schrödinger, founded in 1990, has developed a physics-based software platform that accelerates the discovery of therapeutics and materials, reducing costs compared to traditional methods. The firm employs over 700 personnel and collaborates with partners globally, aiming to address unmet medical needs.

Positive

• Schrödinger's software platform enables faster and cost-effective drug discovery.
• The company collaborates with biopharmaceutical firms, enhancing its market reach.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2022 financial results on Thursday, August 4, 2022, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. To participate in the live call, please register for the call here. It is recommended that participants register at least 15 minutes in advance of the call. Once registered, participants will receive the dial-in information. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.

About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 700 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com follow us on LinkedIn and Twitter, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220721005061/en/

Jaren Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Source: Schrödinger

FAQ

When will Schrödinger release its second quarter 2022 financial results?

Schrödinger will report its second quarter 2022 financial results on August 4, 2022.

What time is the Schrödinger conference call scheduled?

The conference call is scheduled for 4:30 p.m. ET on August 4, 2022.

Where can I access the live webcast of Schrödinger's financial report?

The live webcast can be accessed under 'News & Events' in the investors section of Schrödinger's website.

What is the primary focus of Schrödinger's business?

Schrödinger focuses on transforming drug and materials discovery through a physics-based software platform.